SHARONBIO

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Disclosure of events or information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Pursuant to Regulation 30 (4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para B of Part A of Schedule III, this is to inform you that a fire accident took place during the morning hours on Sunday, February 26, 2023, at the Company s manufacturing unit located at M/s Sharon Bio-Medicine Limited, Plot No L6, MIDC Area, Taloja , Panvel, Dist: Raigad, Maharashtra '.

Sharon Bio-Medicine Limited has informed the Exchange regarding ''.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'With reference to the above referred subject, we are enclosing herewith the Confirmation Certificate dated January 6, 2023 received from M/s. Link Intime India Private Limited, the Registrar and Share Transfer Agent of our Company for the quarter ended December 31, 2022.'.

SHARONBIO: The Company is in receipt of advisory letters from NSE and BSE on December 12, 2022, and December 20, 2022, respectively. It is through the advisory letters that the Company noticed the mistake that it had inadvertently missed mentioning the names of the promoters corresponding to their shareholding in the shareholding patterns filed for the quarters ended December 2020 to September 2022. Immediately upon the receipt of the advisory letters, the Company rectified the same by disclosing the names of the promoters and submitted the updated shareholding patterns to the stock exchanges

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Response to letter received on December 12, 2022 regarding non-compliance withSEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 ( LODR Regulation )'.

Revised Shareholding Pattern from the quarter ended December 2020 to September 2022.

Response to your mail dated 17th November 2022 in the matter of Sharon Bio-Medicine Limited

Sharon Bio-Medicine Limited has informed the Exchange about Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018

Sharon Bio-Medicine Limited has informed the Exchange about Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018

Sharon Bio-Medicine Limited has informed the Exchange about Revised Auditor's Report for the quarter and year ended March 31, 2022

Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Sharon Bio-Medicine Limited has informed the Exchange about Order passed by Hon'ble Supreme Court

Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'NCLAT Order dated January 5, 2022'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Intimation of Closure of Trading Window '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021.Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and half year en

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Intimation of Closure of Trading Window '.

Newspaper Publication of Unaudited Financial Results��

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 Kindly take the same on your record and acknowledge the receipt. '.

Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed from July 1, 2021 till Forty Eight (48) hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2021.��Currently, the trading is temporarily suspended for capital reduction process and would be resumed upon requisite approval from regulators.��Kindly take the above on record.

Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Audited Financial Results of the Company for the quarter and year ended March 31, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Publication for intimation of Audited Financial Results '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Subject: Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Intimation of Closure of Trading Window '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Sub: Newspaper Publication of Unaudited Financial ResultsPursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter and nine months ended December 31, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Sub: Publication for Intimation of Unaudited financial results Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter ended December 31, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Dear Sir/Madam, Subject: Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 With reference to the above referred subject, we are enclosing herewith the Confirmation Certificate dated January 28, 2021 received from M/s. Link Intime India Private Limited, the Register and Share Transfer Agent of our Company for the quarter ended December 31, 2020.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Sub: Newspaper Publication of Unaudited Financial ResultsPursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter and half year ended September 30, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter and half year ended September 30, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Newspaper Publication of Unaudited Financial Results'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter ended June 30, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Disclosure of material impact of COVID 19 pandemic'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Dear Sir/Madam,Sub: Newspaper Publication of Unaudited financial results Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2019.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Dear Sir/Madam,Sub: Publication for Intimation of Unaudited financial results Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter and nine months ended December 31, 2019.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Newspaper Publication of Unaudited Financial Results '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Publication for Intimation of Unaudited financial results '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Intimation/ Disclosure pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 '.

Sharon Bio-Medicine Limited has informed the Exchange regarding ''In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the Certificate dated 16th October, 2019, received from M/s Link Intime (India) Pvt. Ltd., the Registrar and Share Transfer Agent of the Company, for the quarter ended 30th September, 2019.''.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Extension application for conducting Annual General Meeting (AGM) '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Newspaper Publication of Unaudited financial results for the quarter ended June 30, 2019.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Publication for intimation of Unaudited financial results '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 received from M/s. Link Intime India Private Limited, the Registrar and Share Transfer Agent of our Company for the quarter ended June 30, 2019'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Copy of advertisement published in newspaper '.